Neil E. Bhola

3.1k total citations · 1 hit paper
36 papers, 2.1k citations indexed

About

Neil E. Bhola is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Neil E. Bhola has authored 36 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 23 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Neil E. Bhola's work include Cancer-related Molecular Pathways (8 papers), Cancer Cells and Metastasis (7 papers) and Peptidase Inhibition and Analysis (5 papers). Neil E. Bhola is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Cancer Cells and Metastasis (7 papers) and Peptidase Inhibition and Analysis (5 papers). Neil E. Bhola collaborates with scholars based in United States, Germany and China. Neil E. Bhola's co-authors include Carlos L. Arteaga, Jennifer R. Grandis, Justin M. Balko, Melinda E. Sanders, Teresa C. Dugger, M. Gabriela Kuba, Violeta Sánchez, Jamie C. Stanford, Rebecca S. Cook and Sufi M. Thomas and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and PLoS ONE.

In The Last Decade

Neil E. Bhola

36 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer

2013 475 citations Neil E. Bhola, Justin M. Balko et al. profile →

Peers

Neil E. Bhola

ONCOL

PRM

IMMUN

Nandini Dey United States

Bisrat G. Debeb United States

Therese M. Becker Australia

Aya Kobayashi Japan

Ludovica Ciuffreda Italy

Yoshimi Arima Japan

Nila U. Parikh United States

Martín A. Rivas Argentina

Silvestre Vicent Spain

Leslie A. Parsels United States

Nandini Dey United States

Neil E. Bhola

1.4k ×1.1

907 ×0.8

ONCOL

432 ×0.9

365 ×1.0

PRM

164 ×0.8

IMMUN

Citations per year, relative to Neil E. Bhola Neil E. Bhola (= 1×) peers Nandini Dey

Countries citing papers authored by Neil E. Bhola

Since Specialization

Citations

This map shows the geographic impact of Neil E. Bhola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil E. Bhola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil E. Bhola more than expected).

Fields of papers citing papers by Neil E. Bhola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil E. Bhola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil E. Bhola. The network helps show where Neil E. Bhola may publish in the future.

Co-authorship network of co-authors of Neil E. Bhola

This figure shows the co-authorship network connecting the top 25 collaborators of Neil E. Bhola. A scholar is included among the top collaborators of Neil E. Bhola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil E. Bhola. Neil E. Bhola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grandis, Jennifer R., Katherine A. Skorupski, Ning Cheng, et al.. (2025). Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer. Cancer Cell. 43(11). 2051–2068.e9. 2 indexed citations

Bhola, Neil E., Yuping Chen, Kevin X. Chen, et al.. (2023). Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor. Cancer Research Communications. 3(9). 1731–1742. 2 indexed citations

Chakrabarty, Anindita, Neil E. Bhola, Vishnu S. Mishra, et al.. (2019). The H1047R PIK3CA oncogene induces a senescence-like state, pleiotropy and acute HSP90 dependency in HER2+ mammary epithelial cells. Carcinogenesis. 40(10). 1179–1190. 7 indexed citations

Leonard, Brandon, Neil E. Bhola, Hua Li, et al.. (2019). ATR inhibition sensitizes HPV− and HPV+ head and neck squamous cell carcinoma to cisplatin. Oral Oncology. 95. 35–42. 36 indexed citations

Brand, Toni M., Stefan Hartmann, Neil E. Bhola, et al.. (2018). Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer. Cancer Research. 78(9). 2383–2395. 31 indexed citations

O’Keefe, Rachel A., Neil E. Bhola, David Lee, Daniel E. Johnson, & Jennifer R. Grandis. (2018). Abstract 1972: Targeting the IL-6 signaling pathway overcomes cetuximab resistance in head and neck squamous cell carcinoma. Cancer Research. 78(13_Supplement). 1972–1972. 1 indexed citations

Leonard, Brandon, Toni M. Brand, Rachel A. O’Keefe, et al.. (2018). BET Inhibition Overcomes Receptor Tyrosine Kinase–Mediated Cetuximab Resistance in HNSCC. Cancer Research. 78(15). 4331–4343. 70 indexed citations

Jansen, Valerie M., Neil E. Bhola, Joshua A. Bauer, et al.. (2017). Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer. Cancer Research. 77(9). 2488–2499. 171 indexed citations

Fang, Yong, Jun‐Jie Yin, Jian Chen, et al.. (2017). Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers. Science Translational Medicine. 9(392). 170 indexed citations

10.

Brand, Toni M., Stefan Hartmann, Neil E. Bhola, et al.. (2016). Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients. Clinical Cancer Research. 23(12). 3072–3083. 44 indexed citations

11.

Bhola, Neil E., Valerie M. Jansen, James P. Koch, et al.. (2015). Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population. Cancer Research. 76(2). 440–452. 78 indexed citations

12.

Hover, Laura D., Christian D. Young, Neil E. Bhola, et al.. (2015). Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth. Cancer Letters. 368(1). 79–87. 32 indexed citations

13.

Bhola, Neil E., Valerie M. Jansen, Sangeeta Bafna, et al.. (2014). Kinome-wide Functional Screen Identifies Role of PLK1 in Hormone-Independent, ER-Positive Breast Cancer. Cancer Research. 75(2). 405–414. 50 indexed citations

14.

Balko, Justin M., Luis J. Schwarz, Neil E. Bhola, et al.. (2013). Activation of MAPK Pathways due to DUSP4 Loss Promotes Cancer Stem Cell-like Phenotypes in Basal-like Breast Cancer. Cancer Research. 73(20). 6346–6358. 122 indexed citations

15.

Chakrabarty, Anindita, Neil E. Bhola, Cammie R. Sutton, et al.. (2012). Trastuzumab-Resistant Cells Rely on a HER2-PI3K-FoxO-Survivin Axis and Are Sensitive to PI3K Inhibitors. Cancer Research. 73(3). 1190–1200. 101 indexed citations

16.

Bhola, Neil E., Maria L. Freilino, Sonali Joyce, et al.. (2012). Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer. Molecular Cancer Therapeutics. 11(6). 1236–1246. 22 indexed citations

17.

Balko, Justin M., Rebecca S. Cook, David Vaught, et al.. (2012). Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. Nature Medicine. 18(7). 1052–1059. 197 indexed citations

18.

Bhola, Neil E., Sufi M. Thomas, Maria L. Freilino, et al.. (2011). Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab. Clinical Cancer Research. 17(15). 4996–5004. 25 indexed citations

19.

Qi, Yanjun, Harpreet Kaur Dhiman, Neil E. Bhola, et al.. (2009). Systematic prediction of human membrane receptor interactions. PROTEOMICS. 9(23). 5243–5255. 15 indexed citations

20.

Zhang, Weiping, Neil E. Bhola, Shailaja Kalyankrishna, et al.. (2008). Kinin B2 Receptor Mediates Induction of Cyclooxygenase-2 and Is Overexpressed in Head and Neck Squamous Cell Carcinomas. Molecular Cancer Research. 6(12). 1946–1956. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact